BrainsWay Announces Successful Results in Pivotal Multicenter Study Evaluating Deep Transcranial Magnetic Stimulation System as an Aid in Smoking Cessation

    NEXT STORY
    Aptose to Present at 31st Annual Piper Jaffray Healthcare Conference
    PREV STORY
    European Medicines Agency Accepts for Review Marketing Authorization Application for Amarin’s Icosapent Ethyl (Vascepa®) for Reduction of Cardiovascular Risk in High-Risk Patients, as Reflected in REDUCE-IT® Study
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Novavax to Participate in the 4th Annual Guggenheim Boston Healthcare Conference

    GAITHERSBURG, Md., Dec. 06, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced the ...

    author_avatar
    NASDAQ Market News

    RedHill Biopharma Announces New European and Japanese Patents for Talicia®

    author_avatar
    NASDAQ Market News

    NeuroMetrix Reports Results of Large Clinical Study of Quell Wearable Pain Relief

    author_avatar
    NASDAQ Market News